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The following is the second part of a two-part article being offered by the Provider Unit of the Continuing Education
Committee of the American Association of Diabetes Educators. AADE has been approved as a provider of continuing
education in nursing by the Central Regional Accrediting Board of the American Nurses ’ Association. Application for CE
credit has also been made to the American Dietetic Association. Social workers may use this activity for Category II
Credit. Upon successful completion of the posttest (70% correct) and submission of the required processing fee ($10),
participants will be awarded 2.0 Contact Hours of CE credit. Material contained in Part I of this series (TDE, Winter
1987, Vol 13, No. 1, pp 30-35) will also be included on this posttest.
OBJECTIVES FOR PART II: AUTONOMIC NEUROPATHIES
After reading this article, you will be able to:
1) Identify the common autonomic neuropathies associated with diabetes mellitus.
2) List the modes of assessment for autonomic neuropathies.
3) List signs and symptoms associated with each of the following autonomic neuropathies: (a) genitourinary,
(b) gastrointestinal, (c) cardiovascular.
(4) Discuss principles of management for persons with autonomic neuropathy.
Diabetic autonomic neuropathies
(DAN) are clinical syndromes
resulting from impairments of
the autonomic nervous system in
patients with diabetes mellitus.
Since the autonomic nervous
system innervates most body
organs, any or all of those
organs may be affected by DAN.
A high index of suspicion is the
best diagnostic tool. Proper
management, with patient and
family education in its center,
improves the quality of life of
persons with DAN. Undiagnosed
and ignored, DAN could cause
severe disability and even death.
Diabetic autonomic neuropathies (DAN), like distal symmet-
rical neuropathies, can occur in all classes of diabetes. The
longer the duration of the disease, the greater the likelihood
that autonomic neuropathy will occur. 1,2 Autonomic neurop-
athies in diabetes may affect a single organ, but more often
they are widespread (Table 1). They can be easily overlooked
until more dramatic symptoms such as gastroparesis and impo-
tence develop. Symptoms of DAN may be absent or inter-
mittent and some, such as frequent urinary tract infections (in
neurogenic bladder), may seem unrelated to diabetes. How-
ever, appropriate documenting can aid in correctly identify-
ing the etiology of the abnormality. Autonomic neuropathies
may become severe enough to cause serious disability or even
death. As in the case of distal symmetrical neuropathy,
diagnosis of DAN is made by exclusion of other perhaps more
treatable causes. DAN can even affect the ability to maintain
blood glucose in an acceptable range.
In the following paper, we shall discuss the manifestation
of DAN in the more commonly involved organ systems and
present possible therapeutic approaches.
. ,
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Bladder Dysfunction
In its early stages, DAN may cause blunted sensation of the
need to void, resulting in infrequent urination. Later, difficult
bladder emptying, dribbling, and overflow incontinence may
occur. An important point to remember is that neurogenic blad-
der and infrequent voiding may be misinterpreted by both
patient and health care provider as reduced polyuria, an indi-
cation of improved glycemic control. 1,3 Bladder insensitivity
can only be documented by a cystometrogram.
Assessment of later complications of bladder dysfunction
may be made by measuring postvoiding residual urine volume
by ultrasound or transurethral catheterization. A postvoiding
residual volume greater than 150 mL is consistent with the
diagnosis of bladder dysfunction. In older men, a coexisting
prostatic hypertrophy must be ruled out by a manual rectal
examination.
Untreated, neurogenic bladder dysfunction almost always
leads to frequent urinary tract infections (UTI) that may inter-
- fere with diabetic control and, in serious cases, be life threaten-
ing. Frequent UTI may lead to worsening of renal function.
Indeed, repeated UTIs (two or more per year) should alert the
health care provider to the possibility of bladder dysfunction.
Treatment of neurogenic bladder should include vigorous
treatment of UTIs with specific antibiotic, regular scheduling
of urination every two to three hours during waking hours,
and cholinergic stimulating dn~gs.4 4
Diabetes educators who have frequent and regular contact
with their patients can help in early discovery of neurogenic
bladder. In addition, diabetes educators can help the patient
understand the importance of following a regimen of regular
urine voiding. Careful assessment and instruction will help
patients detect their UTIs earlier as well. In elderly patients
with DAN, urinary tract infection may be present without its
classic symptoms (eg, suprapubic discomfort, urinary fre-
quency, urgency, and fever). The only manifestation may be
mild to moderate change in mental status. Family members
must develop a high index of suspicion and promptly report
the possibility of UTI. The importance of patient and health
care professional education in early detection and treatment
of this problem cannot be overemphasized.
Sexual Dysfunction
As many as 50 % of diabetic men and 35 % of diabetic women
have sexual problems due to neuropathy.
In rare cases, the sexual dysfunction may include male retro-
grade ejaculation with a normal libido, normal erection, and
normal orgasm. Diagnosis can be made by recovering live and
mobile sperm in the postcoital urine.
The more common and more disturbing sexual dysfunction
in men with diabetes is impotence. One should be cautious
not to assume that erectile dysfunction in a diabetic man is
always due to autonomic neuropathy. Indeed, more treatable
or curable conditions (eg, drug induced, hormonal deficiency)
must be considered (Fig 1). It is equally important to distin-
guish between psychogenic and organic erectile dysfunction.
In most cases, a careful history can make this distinction.
Whereas psychogenic impotence is relatively abrupt in onset
and may be partner-specific, organic impotence is gradual in
onset and always partner nonspecific. Early morning erection
is present in psychogenic impotence and characteristically
absent in organic impotence. Neurogenic impotence may be
shown by testing for nocturnal penile tumescence (NPT) and
rigidity. In addition, the patient should have normal serum
testosterone, prolactin, and penile blood pressure. Some
patients with neurogenic erectile dysfunction may benefit from
implantation of a penile prosthesis, but a careful discussion
of pros and cons of this procedure with patient and his wife
is imperative
Other methods for the treatment of impotence include vaso-
dilators, injection of papaverine plus phentolamine into the
penis, and mechanical low-pressure devices. These latter
methods are relatively new and require more clinical exper-
ience before they are recommended for widespread use.
In women, sexual dysfunction manifests as difficulty in
attaining vaginal lubrication during stimulation and reduction
in the frequency or absence of orgasm. 1,4 For these patients,
use of estrogen vaginal cream or water-based vaginal lubricants
during intercourse may be of help.
Frank and tactful discussion of sexual problems and logical
and sensible explanation by the diabetes educator go a long
way toward relieving the individual’s anxieties about sexual
dysfunctions. This approach will ultimately assist the patient
and the physician in reaching a more acceptable therapeutic
decision.6 6
Gastrointestinal Neuropathy
Virtually every part of the gastrointestinal (GI) system has
autonomic innervation. Therefore, DAN can produce a cor-
respondingly broad spectrum of GI symptoms. Although
delayed gastric emptying (gastroparesis) is usually asymp-
tomatic, it may be associated with anorexia, early satiety, a
sense of fullness and bloating, and nausea after meals. Ra-
dionuclide studies can document the presence of delayed solid-
phase gastric emptying. This condition can increase the pa-
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Fig 1. Algorithmic approach to impotence.
tient’s susceptibility to postmeal hypoglycemia since the food
is retained in the stomach. High-residue and high-fiber foods
should be avoided.1 1,4 A dose of 10-20 mg of metoclopramide
before meals and at bedtime is usually effective. In severe
cases, the drug should be given parenterally for the first two
to three days to allow emptying and digestion of consumed
food.7 Subsequently, metoclopramide should be given orally.
Decreased small intestinal motility may lead to bacterial
overgrowth and diarrhea. Cramps and pains are commonly
absent. Diarrhea can also occur from hypermotility and without
bacterial overgrowth. Alternatively, diarrhea may result from
pancreatic insufficiency or bile salt malabsorption.
Diarrhea may be nocturnal, intermittent at first, and
associated with fecal incontinence. Diagnosis is one of ex-
clusion. When other causes have been ruled out, a radiologic
study showing a disordered motility pattern, with segmenta-
tion and puddling of barium in the small intestine, suggests
that the problem is neuropathic.4 Metoclopramide, bile salt
sequestrants, and broad spectrum antibiotics have all been
helpful in some cases of diarrhea. But, in the more severe
cases, administering 1-2 tablets of diphenoxylate hydrochloride
with atropine sulfate three to four times daily may be necessary.
Patients with gastroparesis must, therefore, be taught to eat
smaller and more frequent (five times daily) meals. Softer and
more liquid foods should be encouraged, and solid foods must
be avoided.
Cardiovascular Neuropathy
One common manifestation of cardiovascular neuropathy is
a fixed pulse rate of 86-100 beats per minute unresponsive
to stress, exercise, or tilting, indicating cardiac denervation.
DAN can also cause orthostatic hypotension, diagnosed
when blood pressure falls at least 10/20 mm Hg from recum-
bency, while the patient experiences lightheadedness and dizzi-
ness. Diabetic individuals may not develop the tachycardia
that usually accompanies orthostatic hypotension. Symptomatic
individuals may respond to elastic stockings, mineralocorti-
coids (fludrocortisone acetate 0.1-0.3 mg/day), vasoconstric-
tors, and atrial pacing.4,8 The most serious aspect of cardio-
vascular autonomic neuropathy is development of cardiac
denervation syndrome in which the patient may suffer myo-
cardial infarction without experiencing any pain. Indeed, one-
third of diabetic patients who sustain an acute myocardial in-
farction experience no pain.4,9 Following a myocardial infarc-
tion, these patients are at increased risk of premature sudden
death, which may be caused by serious cardiac arrhythmias.
Obviously, these patients are not candidates for an intensive
regimen (due to risk of hypoglycemia, which may cause car-
diac arrhythmias), rigorous exercise program, or even cardiac
exercise testing.
Educators should help patients with cardiovascular neurop-
athy to understand and cope with their clinical condition. Pa-
tients must be instructed to avoid sudden changes of position,
especially from recumbency to upright. This will reduce the
likelihood of patients with postural hypotension becoming
dizzy and falling. Finally, individuals with cardiac denerva-
tion must be cautioned against heavy exercise or straining.
Impaired Glucose Counterregulation
The maintenance of blood glucose levels during periods of
food deprivation or increased insulin action depends on the
integrity of glucagon secretion and the adrenergic nervous
system. Patients with DAN may not only have a defective
adrenergic nervous system but may also suffer from (1) defec-
tive glucagon secretion and (2) &dquo;hypoglycemia unawareness,&dquo;
in which typical adrenergic warning signs of impending neuro-
glucopenia (hunger, tachycardia, diaphoresis, etc) are absent.
It should be emphasized that every patient with long-standing
type I diabetes who is being considered for intensive insulin
therapy should be tested for the integrity of his glucose counter-
regulatory mechanism. Absence of glucagon and epinephrine
response to hypoglycemia induced by a standard dose of in-
sulin is a contraindication for rigorous and tight glucose con-
trol. Importance of food intake in relation to insulin kinetics
(short, intermediate, or long-acting) and the time of insulin
injections must be stressed.
Sudomotor Dysfunction
Sudomotor dysfunction is commonly manifested by anhidrosis
in the lower extremities with a compensatory hyperhidrosis
on the trunk and face. Patients may complain of heat in-
tolerance and excessive sweating on the face and body. The




Diabetic autonomic neuropathy is the name given to a variety
of clinical syndromes, insidious in onset and varied in their
clinical presentation. Diagnosis is made by excluding other
more treatable causes. When fully manifested, DANs can lead
to severe disability or even death. Treatment is primarily sup-
portive and aimed at avoidance of inciting factors. Intensive
glycemic control is contraindicated in the majority of persons
with DAN. Patient education and patient involvement in the
management of DAN are essential if there is to be any chance
for preventing further complications.
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